Terms: = Pancreatic cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Treatment
122 results:
1. Advancements in medical treatment for pancreatic neuroendocrine tumors: A beacon of hope.
Giri S; Sahoo J
World J Gastroenterol; 2024 Mar; 30(12):1670-1675. PubMed ID: 38617746
[TBL] [Abstract] [Full Text] [Related]
2. Epigenetic therapeutic strategies in pancreatic cancer.
Orlacchio A; Muzyka S; Gonda TA
Int Rev Cell Mol Biol; 2024; 383():1-40. PubMed ID: 38359967
[TBL] [Abstract] [Full Text] [Related]
3. NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic pancreatic cancer: A Systematic Review and Meta-Analysis.
Nichetti F; Rota S; Ambrosini P; Pircher C; Gusmaroli E; Droz Dit Busset M; Pusceddu S; Sposito C; Coppa J; Morano F; Pietrantonio F; Di Bartolomeo M; Mariani L; Mazzaferro V; de Braud F; Niger M
JAMA Netw Open; 2024 Jan; 7(1):e2350756. PubMed ID: 38190183
[TBL] [Abstract] [Full Text] [Related]
4. Characterization of circulating miRNAs in the treatment of primary liver tumors.
Umezu T; Tanaka S; Kubo S; Enomoto M; Tamori A; Ochiya T; Taguchi YH; Kuroda M; Murakami Y
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1964. PubMed ID: 38146079
[TBL] [Abstract] [Full Text] [Related]
5. Clinical impact of unsuccessful subcutaneous administration of octreotide LAR instead of intramuscular administration in patients with metastatic gastroenteropancreatic neuroendocrine tumors.
Krishnan T; Safro M; Furlanetto DM; Gill S; Solar Vasconcelos JP; Stuart HC; Martineau P; Loree JM
J Neuroendocrinol; 2024 Jan; 36(1):e13360. PubMed ID: 38088132
[TBL] [Abstract] [Full Text] [Related]
6. Long-term quality of life is better after laparoscopic compared to open pancreatoduodenectomy.
Dagorno C; Marique L; Korrel M; de Graaf N; Thouny C; Renault G; Ftériche FS; Aussilhou B; Maire F; Lévy P; Rebours V; Lesurtel M; Sauvanet A; Dokmak S
Surg Endosc; 2024 Feb; 38(2):769-779. PubMed ID: 38052888
[TBL] [Abstract] [Full Text] [Related]
7. Optimal first-line treatment strategies of systemic therapy for unresectable gastrointestinal neuroendocrine tumors based on the opinions of Japanese experts.
Honma Y; Ikeda M; Hijioka S; Matsumoto S; Ito T; Aoki T; Furuse J
Invest New Drugs; 2023 Dec; 41(6):777-786. PubMed ID: 37856005
[TBL] [Abstract] [Full Text] [Related]
8. Current role of Nuclear Medicine in the diagnosis and therapy of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Georgakopoulos A
Hell J Nucl Med; 2023; 26 Suppl():49-51. PubMed ID: 37658564
[TBL] [Abstract] [Full Text] [Related]
9. Tyrosine Kinase Inhibitors and Immunotherapy Updates in Neuroendocrine Neoplasms.
Mosalem O; Sonbol MB; Halfdanarson TR; Starr JS
Best Pract Res Clin Endocrinol Metab; 2023 Sep; 37(5):101796. PubMed ID: 37414652
[TBL] [Abstract] [Full Text] [Related]
10. Breakthrough Symptoms Remain an Unmet Need in Symptomatic Patients With Neuroendocrine Tumors and Carcinoid Syndrome.
Liu E; Hoffman KD; Murfin G; Eccard H
Pancreas; 2023 Jan; 52(1):e70-e74. PubMed ID: 37378902
[TBL] [Abstract] [Full Text] [Related]
11. The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer: a cross sectional study.
Su YY; Chao YJ; Wang CJ; Liao TK; Su PJ; Huang CJ; Chiang NJ; Yu YT; Tsai HM; Chen LT; Shan YS
Int J Surg; 2023 Sep; 109(9):2614-2623. PubMed ID: 37300888
[TBL] [Abstract] [Full Text] [Related]
12. Survival Benefit of Surgical treatment for Elderly Patients with Intrahepatic Cholangiocarcinoma: A Retrospective Cohort Study in the SEER Database by Propensity Score Matching Analysis.
Chen K; Yu H; Yang J; Bo Z; Jin C; Wu L; Wang Y; Chen G
Curr Oncol; 2023 Feb; 30(3):2642-2652. PubMed ID: 36975414
[TBL] [Abstract] [Full Text] [Related]
13. Case report: Metastatic pancreatic neuroendocrine tumour associated with portal vein thrombosis; successful management with subsequent pregnancies.
Sira L; Zsíros N; Bidiga L; Barna S; Kanyári Z; Nagy EB; Guillaume N; Wild D; Rázsó K; Andó S; Balogh I; Nagy EV; Balogh Z
Front Endocrinol (Lausanne); 2023; 14():1095815. PubMed ID: 36923225
[TBL] [Abstract] [Full Text] [Related]
14. Gastro-Enteric-pancreatic Neuroendocrine Tumor treatment:
Sanli Y; Denizmen D; Subramaniam RM
PET Clin; 2023 Apr; 18(2):201-214. PubMed ID: 36858745
[TBL] [Abstract] [Full Text] [Related]
15. What have we learnt from the past - would treatment decisions for GEP-NET patients differ between 2012 to 2016 by the new recommendations in 2022?
Stiefel R; Lehmann K; Winder T; Siebenhüner AR
BMC Cancer; 2023 Feb; 23(1):148. PubMed ID: 36782152
[TBL] [Abstract] [Full Text] [Related]
16. Somatostatin-analog effect on pancreatic fistula after radical gastrectomy: a pilot randomized controlled trial.
Sha S; Qiao W; Feng R; Lian G; Chen Y; Peng L; Wang J; Li L; Tian F; Jing C
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6329-6339. PubMed ID: 36745222
[TBL] [Abstract] [Full Text] [Related]
17. Resistance of neuroendocrine tumours to somatostatin analogs.
Angelousi A; Koumarianou A; Chatzellis E; Kaltsas G
Expert Rev Endocrinol Metab; 2023 Jan; 18(1):33-52. PubMed ID: 36651768
[TBL] [Abstract] [Full Text] [Related]
18. Differential Effects of Somatostatin, Octreotide, and Lanreotide on Neuroendocrine Differentiation and Proliferation in Established and Primary NET Cell Lines: Possible Crosstalk with TGF-β Signaling.
Ungefroren H; Künstner A; Busch H; Franzenburg S; Luley K; Viol F; Schrader J; Konukiewitz B; Wellner UF; Meyhöfer SM; Keck T; Marquardt JU; Lehnert H
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555512
[TBL] [Abstract] [Full Text] [Related]
19. Commiphora myrrha stimulates insulin secretion from β-cells through activation of atypical protein kinase C and mitogen-activated protein kinase.
Al-Romaiyan A; Masocha W; Oyedemi S; Marafie SK; Huang GC; Jones PM; Persaud SJ
J Ethnopharmacol; 2023 Feb; 302(Pt B):115937. PubMed ID: 36410575
[TBL] [Abstract] [Full Text] [Related]
20. Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation.
Kjaer J; Smith S; Hellman P; Stålberg P; Crona J; Welin S; Norlén O
World J Surg; 2023 Feb; 47(2):340-347. PubMed ID: 36175647
[TBL] [Abstract] [Full Text] [Related]
[Next]
